• GRK Control of Biased M1 Receptor Signaling

  2026-08-28

  A 2025 study used quantitative BRET assays to show that GRK subtype behavior helps determine how the M1 muscarinic receptor engages G proteins and β-arrestin 2. Its analysis of BQCA further indicates that this allosteric modulator can activate M1-associated protein interactions alone and increase acetylcholine sensitivity across both signaling systems.

• EPZ-6438: Selective EZH2 Inhibitor Guide

  2026-08-28

  EPZ-6438 is a selective EZH2 inhibitor that blocks SAM-dependent PRC2 methyltransferase activity and reduces H3K27me3. Its nanomolar biochemical activity and activity in SMARCB1-deficient, EZH2-mutant lymphoma, and HPV-associated cancer models support its use in epigenetic cancer research.

• CLCC1 and Herpesvirus Nuclear Egress: Study Insights

  2026-08-27

  The reference preprint identifies the host factor CLCC1 as essential for membrane fusion during herpesvirus nuclear egress, distinguishing this poorly understood step from viral capsid envelopment. Its CRISPR-screen and cell-biological findings connect herpesvirus release with nuclear pore complex insertion and suggest an evolutionarily conserved membrane-remodeling mechanism.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-27

  The 2024 Development study links SMPD4-dependent ceramide production to primary cilium formation and brain development across mouse and human cellular models. Its rescue experiments provide a mechanistic framework for understanding why SMPD4 variants cause microcephaly, cerebellar hypoplasia, and neural progenitor defects.

• Tetrandrine: From Ion Channels to Assay Design

  2026-08-26

  Tetrandrine is a versatile Tetrandrine alkaloid for calcium-channel, inflammation, neuroscience, and cancer biology research. This assay-first guide connects its physicochemical properties with rigorous workflow design and explains how natural-product screening evidence should shape—not overstate—mechanistic conclusions.

• Atrial Natriuretic Peptide: Rat Workflow Guide

  2026-08-26

  Build reproducible rat cardiovascular experiments around Atrial Natriuretic Peptide, from solution preparation through renal, vascular, and adipose readouts. The workflow also shows how causal-control logic from a neuroinflammation study can strengthen ANP study design without confusing adiponectin biology with ANP activity.

• Nuclear cGAS Restricts L1 Retrotransposition

  2026-08-25

  The reference study identifies a DNA damage-responsive CHK2–cGAS–TRIM41 pathway that limits LINE-1 retrotransposition by destabilizing the L1-encoded ORF2p protein. Its findings expand the role of nuclear cGAS from genome surveillance to post-translational control of mobile genetic elements, with implications for genome integrity, cellular senescence, and tumor biology.

• BI 2536: Turning PLK1 Biology into Translational Insight

  2026-08-25

  A mechanistic and strategic guide to using BI 2536 as a selective PLK1 inhibitor for dissecting mitotic checkpoint control, G2/M arrest, apoptosis, and translational cancer research decisions.

• RG7388: A Mechanistic Guide to MDM2–p53 Research

  2026-08-24

  RG7388 is a selective MDM2 antagonist for testing p53 pathway activation and cancer cell apoptosis induction in wild-type p53 models. This article connects its pharmacology with new evidence on MDM1, YBX1, and chemoradiotherapy sensitivity to improve assay interpretation and translational study design.

• PPM-18 for NF-κB and iNOS Research

  2026-08-24

  PPM-18 enables a focused way to connect NF-κB activation with downstream iNOS expression, nitrite release, and inflammatory cytokines. This workflow-oriented guide covers cell-based inflammation assays, sepsis research considerations, practical controls, and troubleshooting for a chemically defined naphthoquinone derivative.

• SIRT4, Glutamine Metabolism, and Liver Fibrosis

  2026-08-23

  The reference study identifies a metabolic vulnerability in activated hepatic stellate cells: dependence on glutamine catabolism through glutamate dehydrogenase. Its central finding is that reduced SIRT4 activity permits GDH-driven production of α-ketoglutarate, supporting stellate-cell proliferation and fibrosis, whereas GDH inhibition or modest SIRT4 overexpression attenuates disease-associated responses.

• HyperScribe™ Poly (A) Tailing Kit Guide

  2026-08-22

  A scenario-based guide to using HyperScribe™ Poly (A) Tailing Kit, SKU K1053, to prepare translation-ready RNA for transfection and phenotype-focused experiments. It connects polyadenylation chemistry with practical controls for cell viability, proliferation, and cytotoxicity assays.

• Leucovorin Calcium in Tumor–Stroma Drug Testing

  2026-08-22

  Leucovorin Calcium, or calcium folinate, can serve as both a methotrexate-rescue reagent and a mechanistic control in patient-derived gastric cancer assembloids. This article outlines how translational teams can use folate biology, matched tumor–stroma models, and assay controls to interpret drug response and resistance more rigorously.

• Sodium salicylate as an NF-κB inhibitor in stroma research

  2026-08-21

  Sodium salicylate provides a practical small-molecule perturbation for linking NF-κB activity, oxidative stress, and stromal inflammation in cell and 3D tumor models. This workflow-oriented guide shows how to benchmark it against the sequential, stroma-remodeling nanomedicine reported in pancreatic cancer research without overstating what that study demonstrated.

• Atrial Natriuretic Peptide: Assay Guide

  2026-08-20

  A practical, scenario-based guide to using Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009) in cell viability, proliferation, and cytotoxicity workflows. It addresses formulation, storage, assay controls, data interpretation, and evidence-based vendor selection for cardiovascular and metabolic research.

7922 records 3/529 page Previous Next 12345 下5页 Last page